Concordia CEO Thompson to Step Down at Specialty Pharma Company
- Search process is under way for new chief executive officer
- Thompson will also resign from the board of directors
This article is for subscribers only.
Concordia International Corp. announced that its founder, Chairman and Chief Executive Officer Mark Thompson, will leave the specialty pharmaceutical company once a successor is named.
The company’s shares surged 19 percent to $4.75 at 2:40 p.m. in New York, after earlier trading as high as $5.55, the biggest gain since January 2014. The shares are down 85 percent in the past 12 months through Thursday.